237 related articles for article (PubMed ID: 27872064)
1. Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains.
Abdelhady W; Bayer AS; Gonzales R; Li L; Xiong YQ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872064
[TBL] [Abstract][Full Text] [Related]
2. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
Xiong YQ; Hady WA; Bayer AS; Chen L; Kreiswirth BN; Yang SJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5528-33. PubMed ID: 22890759
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of telavancin and daptomycin in experimental endocarditis due to multi-clonotype MRSA strains.
Xiong YQ; Abdelhady W; Tang C'; Bayer AS
J Antimicrob Chemother; 2016 Oct; 71(10):2890-4. PubMed ID: 27353467
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
Yang SJ; Xiong YQ; Boyle-Vavra S; Daum R; Jones T; Bayer AS
Antimicrob Agents Chemother; 2010 Aug; 54(8):3161-9. PubMed ID: 20547804
[TBL] [Abstract][Full Text] [Related]
5. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
6. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Steed ME; Vidaillac C; Rybak MJ
Antimicrob Agents Chemother; 2012 Feb; 56(2):955-9. PubMed ID: 22123693
[TBL] [Abstract][Full Text] [Related]
8. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
García-de-la-Mària C; Gasch O; García-Gonzalez J; Soy D; Shaw E; Ambrosioni J; Almela M; Pericàs JM; Tellez A; Falces C; Hernandez-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Pujol M; Moreno A; Marco F; Miró JM
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
[TBL] [Abstract][Full Text] [Related]
9. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.
Yang SJ; Nast CC; Mishra NN; Yeaman MR; Fey PD; Bayer AS
Antimicrob Agents Chemother; 2010 Aug; 54(8):3079-85. PubMed ID: 20498310
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus.
Huang DB; Gaukel E; Kerzee N; Borroto-Esoda K; Lowry S; Xiong YQ; Abdelhady W; Bayer AS
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0050821. PubMed ID: 34097491
[TBL] [Abstract][Full Text] [Related]
11. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
Taglialegna A; Varela MC; Rosato RR; Rosato AE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Joson J; Grover C; Downer C; Pujar T; Heidari A
J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600
[No Abstract] [Full Text] [Related]
13. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
Ruggero MA; Peaper DR; Topal JE
Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
[TBL] [Abstract][Full Text] [Related]
14. Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Camou F
J Antimicrob Chemother; 2012 Feb; 67(2):514; author reply 515. PubMed ID: 22081266
[No Abstract] [Full Text] [Related]
15. Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Cleveland KO; Memon KA
J Antimicrob Chemother; 2011 Dec; 66(12):2891; author reply 2891-2. PubMed ID: 21903659
[No Abstract] [Full Text] [Related]
16. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
Chambers HF; Basuino L; Hamilton SM; Choo EJ; Moise P
Antimicrob Agents Chemother; 2016 Jul; 60(7):3976-9. PubMed ID: 27090173
[TBL] [Abstract][Full Text] [Related]
18. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122892
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
20. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
Mendes RE; Sader HS; Flamm RK; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2015 Mar; 59(3):1811-4. PubMed ID: 25561335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]